Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Five Competitors Confirmed On Canadian Adalimumab
Amgen, Fresenius, Merck And Viatris Confirm Further Launches Of Humira Biosimilars
Feb 18 2021
•
By
David Wallace
Multiple biosimilars to adalimumab are duking it out in Canada • Source: Shutterstock
More from Biosimilars
More from Products